Related Experiment Video
Updated: Oct 7, 2025
04:13
Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
490
A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic
The Journal for Nurse Practitioners : JNP
|January 11, 2022
Summary
Buprenorphine treatment program attendance remained high during COVID-19, with telemental health proving a viable option. Patient therapy participation significantly changed, highlighting the need for flexible service delivery in addiction treatment.
Area of Science:
- Addiction Medicine
- Public Health
- Telehealth
Background:
- Buprenorphine treatment is crucial for opioid use disorder.
- The COVID-19 pandemic disrupted traditional healthcare delivery.
- Evaluating service continuity in addiction treatment is essential.
Purpose of the Study:
- To assess the impact of COVID-19 on buprenorphine treatment program attendance.
- To compare patient recovery metrics between pre- and post-pandemic service methods.
- To evaluate the viability of telemental health in buprenorphine management programs.
Main Methods:
- Medical record review of 28 adult patients.
- Cross-sectional comparison of pre-COVID-19 and during-COVID-19 data.
- Analysis of attendance rates and therapy participation.
Main Results:
- Mean attendance rates showed no significant difference (99.46% vs 96.13%).
- Patient participation in therapy significantly differed between periods (p=0.03).
- Telemental health emerged as a viable alternative service method.
Conclusions:
- Buprenorphine treatment programs maintained high attendance during the pandemic.
- Telemental health services can effectively support addiction treatment continuity.
- Adapting service delivery models is key for sustained patient engagement.
More Related Videos
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
491
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
491
01:17Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
273
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
273
01:26Drug Administration and Therapy Phases: Overview
832
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
832
01:15Drug Abuse and Addiction: Pharmacological Phenomena
780
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
780
01:19Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K